Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H30O2 |
Molecular Weight | 290.4403 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@@]4([H])C[C@@H](O)CC[C@]34C
InChI
InChIKey=QGXBDMJGAMFCBF-LUJOEAJASA-N
InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,18-,19-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/22037250Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7726568 | https://www.ncbi.nlm.nih.gov/pubmed/12054855 | https://www.ncbi.nlm.nih.gov/pubmed/15650074 | https://www.ncbi.nlm.nih.gov/pubmed/17017935
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22037250
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/7726568 | https://www.ncbi.nlm.nih.gov/pubmed/12054855 | https://www.ncbi.nlm.nih.gov/pubmed/15650074 | https://www.ncbi.nlm.nih.gov/pubmed/17017935
The 17-ketosteroid epiandrosterone is a metabolite of testosterone precursor dehydroepiandrosterone (DHEA).
Epiandrosterone have been considered to be merely inactive end product of DHEA, but may in fact be physiological effectors in their own right. It is formed in peripheral tissues, from which it is released into the circulation and is ultimately excreted in the urine. Epiandrosterone is only a weak androgen, but it is widely recognized to inhibit the pentose phosphate pathway and to decrease intracellular NADPH levels. Epiandrosterone may act as a L-type Ca2+ channel antagonist. Epiandrosterone mainly transformed into 17beta-hydroxylated derivatives, 7- or 16alpha-hydroxylated metabolites under NAD(P)H conditions, and 5alpha-androstane-3,17-dione under NAD(P)+ conditions. Epiandrosterone is used as an anabolic agent (dietary supplement, a precursor to dihydrotestosterone) to increase strength, muscle hardness and also improves libido.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22508085
Curator's Comment: Androsterone injections increased brain levels of epiandrosterone in rats. No human data available.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095229 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12054855 |
|||
Target ID: CHEMBL5347 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7726568 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Inhibitors of pentose phosphate pathway cause vasodilation: involvement of voltage-gated potassium channels. | 2002 Apr |
|
Use of bioconversion for the preparation of [4-14C]-labeled 7 alpha- and 7 beta-hydroxylated derivatives of dehydroepiandrosterone and epiandrosterone. | 2002 Dec |
|
The effect of isoflavone extract ingestion, as Trinovin, on plasma steroids in normal men. | 2002 Jan |
|
Epiandrosterone, a metabolite of testosterone precursor, blocks L-type calcium channels of ventricular myocytes and inhibits myocardial contractility. | 2002 Jun |
|
A facile and high yielding synthesis of 2,2,3,4,4-d5-androsterone-beta-D-glucuronide--an internal standard in dope. | 2003 Jan |
|
Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines. | 2003 Jan |
|
Hypoxia promotes relaxation of bovine coronary arteries through lowering cytosolic NADPH. | 2006 Jun |
|
Steroid hormone related male biased parasitism in chamois, Rupicapra rupicapra rupicapra. | 2006 Jun 15 |
|
Effects of mutation at the D-JH junction on affinity, specificity, and idiotypy of anti-progesterone antibody DB3. | 2006 Sep |
|
Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids. | 2007 Jun 27 |
|
Isolation and identification of diglucuronides of some endogenous steroids in dogs. | 2008 Feb |
|
Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants. | 2009 Jun 2 |
|
Revealing genes associated with vitellogenesis in the liver of the zebrafish (Danio rerio) by transcriptome profiling. | 2009 Mar 31 |
|
16-bromoepiandrosterone, an activator of the mammalian immune system, inhibits glucose 6-phosphate dehydrogenase from Trypanosoma cruzi and is toxic to these parasites grown in culture. | 2010 Jul 1 |
|
Determination of (13)C/(12)C ratios of endogenous urinary steroids excreted as sulpho conjugates. | 2010 Nov 15 |
|
Steroid degradation genes in Comamonas testosteroni TA441: Isolation of genes encoding a Δ4(5)-isomerase and 3α- and 3β-dehydrogenases and evidence for a 100 kb steroid degradation gene hot spot. | 2010 Oct |
Sample Use Guides
Epiandrosterone is used as an anabolic agent (dietary supplement). Recommended dosing is 300-400 mg for a 6-8 week cycle.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12933338
Epiandrosterone (1-500 uM) elicited dose-dependent relaxation in chemically contracted endothelium-removed bovine coronary arteries
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
2229-3
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
||
|
CFR |
21 CFR 862.1430
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
||
|
DSLD |
2986 (Number of products:14)
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
||
|
NCI_THESAURUS |
C243
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Epiandrosterone
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
441302
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | |||
|
207-563-3
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | |||
|
C61747
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | |||
|
541975
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | |||
|
481-29-8
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | |||
|
DTXSID20289698
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | |||
|
m4934
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | Merck Index | ||
|
93996
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | |||
|
EPIANDROSTERONE
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY | |||
|
8TR252Z538
Created by
admin on Fri Dec 15 15:19:53 GMT 2023 , Edited by admin on Fri Dec 15 15:19:53 GMT 2023
|
PRIMARY |
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
SUBSTANCE RECORD